www.moovcare.com
Open in
urlscan Pro
62.128.51.10
Public Scan
Submitted URL: http://moovcare.com/
Effective URL: https://www.moovcare.com/
Submission: On March 06 via api from US — Scanned from DE
Effective URL: https://www.moovcare.com/
Submission: On March 06 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMName: exit-contact-form — POST https://www.moovcare.com/thanks/?exitPopup=1
<form action="https://www.moovcare.com/thanks/?exitPopup=1" method="post" id="exit-contact-form" name="exit-contact-form">
<div class="main-contact-form full-div">
<div class="contact-form-field-container">
<!--email -->
<input type="text" value="Email" placeholder="Email" id="exitContactEmail" name="jf_txt_3" alt="Email" title="Email" class="form-field blurme">
</div>
<div class="full-div">
<div class="contact-form-submit ">
<input style="background-color: #ff5355;" type="button" id="exit-contact-submit" class="genral-button hand c-white transition-bg-color" placeholder="SEND" alt="Submit" title="Submit" value="Submit">
<div class="contact-submit-arr">
<img style="max-width:25px;margin: auto;" src="images/white-arr-right.svg" alt="">
</div>
</div>
</div>
</div>
</form>
Text Content
SIGN UP FOR OUR NEWSLETTER PLEASE CHOOSE I Confirm I am aPatient / Carer I Confirm I am aHealthcare Professional en | fr | ger Moovcare Log In AS PATIENT AS PHYSICIAN HOME WHO BENEFITS TEAM CLINICAL DEVELOPMENT PUBLICATIONS & NEWS TESTIMONIALS CONTACT IT'S NEVER TOO EARLY TO DETECT RELAPSE MOOVCARE® ALERTS YOU TO THE FIRST SIGNS OF TROUBLE SO YOU CAN INTERVENE SOONER hp_lungs WHAT IS MOOVCARE®? Moovcare® is a digital therapeutic that uses a simple weekly questionnaire to detect relapse or complication during follow-up of lung cancer patients A Class I medical device, Moovcare® has been proven in clinical trials to improve overall survival by 7.6 months For more information download our brochure Improvement in overall survival +7.6 months HOW EARLY DETECTION IMPROVES SURVIVAL Moovcare® dramatically improves survival by monitoring patient symptoms on a weekly basis and alerting medical teams to the first signs of an anomaly - allowing for early intervention when the likelihood of successful treatment is highest. DETECT EARLIER CT scans can detect anomalies too late for doctors to treat effectively. Moovcare monitors and analyzes patient reported symptoms weekly for the first signs of trouble. INTERVENE SOONER The moment an anomaly is detected, an alert is sent to the care team, enabling them to make an informed decision on whether and how to investigate the matter further. OFFER OPTIMAL TREATMENT By intervening as soon as possible, before the patient’s health deteriorates, the physician can offer the optimum treatment - thereby increasing the chances of survival and improving quality of life. MOOVCARE® HAS PROVED TO BE AN ACCURATE SUPPORT TOOL WITH 100% SENSITIVITY AND 89% SPECIFICITY MEET MOOVCARE® THE RIGHT TREATMENT AT THE RIGHT TIME STANDARD LUNG CANCER FOLLOW-UP. Problem discovered weeks or months after event MOOVCARE® LUNG CANCER FOLLOW-UP. Caregiver alerted the moment a problem is detected HOW MOOVCARE® WORKS 1 PHYSICIAN PRESCRIBES MOOVCARE® TO PATIENT 2 PATIENT REPORTS SYMPTOMS WEEKLY VIA WEB SURVEY 3 ALGORITHM ANALYZES THE SYMPTOMS 4 IF AN ANOMALY IS DETECTED, ALERT SENT TO MEDICAL TEAM FOR FURTHER INVESTIGATION The patient can also use Moovcare® to report symptoms they experience between scheduled visits A NEW REALITY IN LUNG CANCER FOLLOW-UP The Moovcare® advantage Improvement on standard follow-up Frequency of follow-up Weekly updates on the patient’s condition Provides continuous clinical vision between scheduled visits and CTs General approach Proactive and dynamic Adds agility to care in response to changing conditions Timing Earliest possible detection offers improved overall survival Identify problems weeks and months earlier than before Patient involvement Patient directly involved in monitoring their own health Patient empowered, reassured through the active role they play Communication Reassured by constant communication with caregiver Healthier state-of-mind, better qualityof life Home Who Benefits Team Clinical Development Publications & News Testimonials Contact Terms Privacy ABOUT SIVAN Find out more about sivan: website: www.sivan-innovation.com MOOVCARE® LUNG: class I medical device Web application for personalized telemonitoring of lung cancer patient SIVAN INNOVATION (Corporate headquarters) Hatidhar 15, Raanana, Israel SIVAN FRANCE (European representative) 6 rue Paul Baudry 75008 Paris, France Current IFU for healthcare professionals Previous versions of the Instructions for use © All rights reserved to Sivan Innovation LTD | Design & development by: Webnoise This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.